ELAVL1 and Parkinson disease: The single-gene enrichment analysis of ELAVL1 in MDD patients in this study showed enrichment in pathways such as Alzheimer’s disease, neurodegenerative disease pathways, Parkinson’s disease, and cellular senescence.